期刊文献+

Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators

下载PDF
导出
摘要 BACKGROUND Von-Willebrand factor(vWF)disposes certain prognostic value in patients with liver cirrhosis,but its relation to other prognostic indicators has not been fully investigated.AIM To analyze the relation between vWF and other prognostic indicators in cirrhotic patients and to evaluate its prognostic value for mortality.METHODS This analytic prospective study was carried out in a tertiary center and initially enrolled 71 patients with liver cirrhosis and portal hypertension.It analyzed the relation between vWF and the stage of the disease and several inflammatory and prognostic indicators.The prospective analysis,performed on a sample of 63 patients,evaluated the association between the selected variables[vWF,Model for End-stage Liver Disease(MELD)score,C-reactive protein(CRP),ferritin,vitamin D,activated partial thromboplastin time,thrombin time,D-dimer concentration]and the survival time as well as their predictive value in terms of 3-mo,6-mo and 1-year mortality.RESULTS vWF was significantly higher in patients with higher Child-Turcotte-Pugh class(P=0.0045),MELD group(P=0.0057),ferritin group(P=0.0278),and D-dimer concentration(P=0.0232).vWF significantly correlated with D-dimer concentration,ferritin,CRP,International Normalized Ratio,and MELD,Child-Turcotte-Pugh,Sequential Organ Failure Assessment,and CLIF-consortium organ failure(CLIF-C OF)scores.vWF,MELD score,and CRP were significantly associated with death and were significant predictors of 3-mo,6-mo,and 1-year mortality.Each vWF unit significantly increased the probability for 3-mo mortality by 1.005 times(P=0.008),for 6-mo mortality by 1.006 times(P=0.005),and for 1-year mortality by 1.007 times(P=0.002).There was no significant difference between the diagnostic performance of vWF and MELD score and also between vWF and CRP regarding the 3-mo,6-mo,and 1-year mortality.CONCLUSION In patients with liver cirrhosis,vWF is significantly related to other prognostic indicators and is a significant predictor of 3-mo,6-mo,and 1-year mortality similar to MELD score and CRP.
出处 《World Journal of Hepatology》 2022年第4期812-826,共15页 世界肝病学杂志(英文版)(电子版)
  • 相关文献

参考文献4

二级参考文献40

  • 1Vukovich T, Teufelsbauer H, Fritzer M, et al. Hemostasis activation in patients with liver cirrhosis. Thromb Res, 1995,77: 271-278.
  • 2Violi F, Leo R, Vezza E, et al. Bleeding time in patients with cirrhosis:relation with degree of liver failure and clotting abnormalities. C A L C Group. Coagulation Abnormalities in Cirrhosis Study Group. J Hepatol, 1994, 20: 531-536.
  • 3Sallah S, Bobzien W Bleeding problems in patients with liver disease:ways to manage the many hepatic effects on coagulation. Postgrad Med,1999,106: 187-190,193-195.
  • 4Levesque E, Hoti E, Azoulay D, Icha- P, Habouchi H, CastaingD, Samuel D, Saliba F. Prospective evaluation of the prognosticscores for cirrhotic patients admitted to an intensive care unit.J Hepatol 2012; 56: 95-102 [PMID: 21835136 DOI: 10.1016/j.jhep.2011.06.024].
  • 5Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levelsof C-reactive protein and procalcitonin in critically ill patients withcirrhosis of the liver. J Lab Clin Med 2005; 146: 347-351 [PMID:16310518].
  • 6Park WB, Lee KD, Lee CS, Jang HC, Kim HB, Lee HS, Oh MD,Choe KW. Production of C-reactive protein in Escherichia coliinfectedpatients with liver dysfunction due to liver cirrhosis.Diagn Microbiol Infect Dis 2005; 51: 227-230 [PMID: 15808312].
  • 7Devaraj S, Kumaresan PR, Jialal I. C-reactive protein inducesrelease of both endothelial microparticles and circulating endothelialcells in vitro and in vivo: further evidence of endothelial dysfunction.Clin Chem 2011; 57: 1757-1761 [PMID: 21980169 DOI: 10.1373/clinchem.2011.169839].
  • 8Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C,Nguyen-Khac E, Duhamel C, Lebrec D, Poynard T, Moreau R.Model for end-stage liver disease score and systemic inflammatoryresponse are major prognostic factors in patients with cirrhosis andacute functional renal failure. Hepatology 2007; 46: 1872-1882[PMID: 17972337].
  • 9Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F,Monnet E, Di Martino V. C-reactive protein predicts short-termmortality in patients with cirrhosis. J Hepatol 2012; 56: 1299-1304[PMID: 22314431 DOI: 10.1016/j.jhep.2011.12.030].
  • 10Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J,Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, WendonJ, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M,Arroyo V. Acute-on-chronic liver failure is a distinct syndromethat develops in patients with acute decompensation of cirrhosis.Gastroenterology 2013; 144: 1426-1437, 1437.e1-9 [PMID:23474284 DOI: 10.1053/j.gastro.2013.02.042].

共引文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部